Clinical and Microbiological Relationships Between Periodontitis and Abdominal Aorta Aneurism: an Case Control Study
1 other identifier
observational
61
0 countries
N/A
Brief Summary
Aorta Abdominal aneurism (AAA) is a chronic degenerative disorder leading to the dilation and eventually to the rupture of the aortic wall. The pathology presents risk factors such as aging, atherosclerosis, male gender, cigarette smoking, pulmonary emphysema and high blood pressure.The vascular wall destruction is characterized by a remodeling of the extracellular matrix (ECM), the presence of an inflammatory infiltrate of macrophages and lymphocytes associated increase in production of MMPs. A similar destruction mechanisms is found in periodontitis a chronic inflammatory diseases characterized by gram-negative bacteria species that are able to degrade ECM of the tooth supporting tissues and leading finally to tooth loss .Moreover, relationships between periodontitis and cardiovascular disease have already been demonstrated. These associations are considered to be initiated by transient or prolonged bacteremia due to dissemination of oral bacteria or their products into the bloodstream . The periopathogens, more specifically Porphyromonas gingivalis (Pg), were observed in atherosclerosis and aneurysm specimens as well as in coronary heart disease and endocarditis The association between periodontitis and Abdominal Aortic Aneurysms (AAA) has not often been studied especially from a clinical aspect. The mechanisms that induce the initiation, the development or the recurrence and the rupture of AAA after a period of quiescence not well studied and are therefore still unknown. The aim of this clinical observational case controlled study is to search for a possible relationship between periodontal disease and rapid growth of AAA. Patients presenting stable or unstable AAA will be screened for the degree of periodontitis, for the type of oral microbiology and periodontopathogen markers present in the blood stream.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2015
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedFirst Submitted
Initial submission to the registry
October 26, 2018
CompletedFirst Posted
Study publicly available on registry
December 6, 2018
CompletedDecember 14, 2018
December 1, 2018
4 months
October 26, 2018
December 12, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
pocked depth correlated with AAA stability
Periodontal clinical parameters such as pocked depth (PD, millimeter) will be correlated with AAA stability.
june 2017
Secondary Outcomes (1)
pocked depth correlated with abdominal aortic aneurysm diametres such as anterior -posterior
March 2018
Study Arms (2)
Stable AAA
= patients with a small abdominal aortic aneursym diameter \< 55 mm "
instable AAA
=patients with a large abdominal aortic aneursym diameter \> 55 mm and/or AAA with rapid growth who needs open surgery or EndoVascular Aneurysm Repair "EVAR
Interventions
Eligibility Criteria
Patients from the Cardiovascular Surgery Department, University Hospital of Liège (Belgium) and presenting AAA were screened in order to include 31 patients in each group (stable versus instable AAA) according to the sample size calculation. Sixty-two patients were therefore included according to the following inclusion and exclusion criteria:
You may qualify if:
- AAA
- dentulous
- ability to come in Hospital
You may not qualify if:
- diseases of connective tissue: rheumatoid arthritis, systemic lupus erythematosus, systemic sclerodermia, Crohn disease, Marfan syndrome, Heler Danlos syndrome, polymyosite/dermatomyosite, mix connectivite (MCDT)
- aneurysms of the lower limbs (femoral or popliteal)
- contraindication to the scanner
- participation of another clinical trial 30 days before baseline
- patient with risk oslerien
- obese patients (BMI ≥ 30 kg/m2)
- immunosuppressant drugs or chemotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Liegelead
- KU Leuvencollaborator
Biospecimen
saliva, sub-gingival and supra-gingival samples
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor of Dental Surgery (DDS), Master of sciences (MS), PhD student
Study Record Dates
First Submitted
October 26, 2018
First Posted
December 6, 2018
Study Start
February 1, 2015
Primary Completion
June 1, 2015
Study Completion
March 1, 2018
Last Updated
December 14, 2018
Record last verified: 2018-12